Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 23;10(9):e1700.
doi: 10.1097/TXD.0000000000001700. eCollection 2024 Sep.

Impact of Intrapatient Immunosuppression Variability in Liver Transplantation Outcomes: A Systematic Review and Meta-analysis

Sherene Lattimore  1 , Anastasia Chambers  1 , Isabella Angeli-Pahim  1 , Abhishek Shrestha  1 , Benjamin O Eke  1 , Ariel Pomputius  2 , Carma Bylund  3 , Megan E Gregory  3 , Ali Zarrinpar  4
Affiliations

Impact of Intrapatient Immunosuppression Variability in Liver Transplantation Outcomes: A Systematic Review and Meta-analysis

Sherene Lattimore et al. Transplant Direct. .

Abstract

Background: To investigate the impact of intrapatient variability (IPV) in the levels of immunosuppressant drugs on health outcomes after liver transplantation.

Methods: A comprehensive systematic review and meta-analysis were conducted, examining literature from MEDLINE/PubMed, Embase, Web of Science, Cochrane Reviews, and Cochrane CENTRAL.

Results: The analysis focused on acute rejection, graft survival, acute kidney injury, and cancer risk as health outcomes. Of 2901 articles screened, 10 met the inclusion criteria. The results indicate a 19% reduction in the risk of acute rejection in patients with lower IPV (RR = 0.81; 95% confidence interval, 0.66-0.99), although 6 studies found no significant association between high IPV and acute rejection. Contrasting results were observed for graft survival, with 1 study indicating worse outcomes for high IPV, whereas another reported no significant difference. High IPV was consistently associated with acute kidney injury across 3 studies. One study suggested a link between high IPV and hepatocellular carcinoma, although a meta-analysis for these outcomes was not feasible.

Conclusions: These findings point to a marginal but statistically significant association between high IPV and an increased risk of acute rejection, highlighting the importance of precise management of immunosuppressive drugs in liver transplant recipients to enhance patient outcomes.

PubMed Disclaimer

Figures

None
Graphical abstract
FIGURE 1.
FIGURE 1.
PRISMA flowchart. PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analysis.
FIGURE 2.
FIGURE 2.
Meta-analysis Forest plot: study characteristics (n = 6). RE, regression model.
FIGURE 3.
FIGURE 3.
SE Funnel plot for publication bias.
See this image and copyright information in PMC

References

    1. UNOS. United Network for Organ Sharing (UNOS). Published 2023. Available at https://unos.org/. Accessed November 27, 2023.
    1. Olsacher A, Bade C, Ehlers J, et al. . How to effectively communicate health information on social media depending on the audience’s personality traits: an experimental study in the context of organ donation in Germany. Soc Sci Med. 2023;335:116226. - PubMed
    1. de Oliveira JTP, Kieling CO, da Silva AB, et al. . Variability index of tacrolimus serum levels in pediatric liver transplant recipients younger than 12 years: non-adherence or risk of non-adherence? Pediatr Transplant. 2017;21. - PubMed
    1. Maciel NB, Schwambach KH, Blatt CR. Liver transplantation: tacrolimus blood levels variation and survival, rejection and death outcomes. Arq Gastroenterol. 2021;58:370–376. - PubMed
    1. Defrancq C, De Wilde N, Raes A, et al. . Intra-patient variability in tacrolimus exposure in pediatric liver transplant recipients: evolution, risk factors, and impact on patient outcomes. Pediatr Transplant. 2019;23:e13388. - PubMed

LinkOut - more resources